323 related articles for article (PubMed ID: 11566946)
1. Angiotensin II and renal fibrosis.
Mezzano SA; Ruiz-Ortega M; Egido J
Hypertension; 2001 Sep; 38(3 Pt 2):635-8. PubMed ID: 11566946
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.
Ruiz-Ortega M; Ruperez M; Lorenzo O; Esteban V; Blanco J; Mezzano S; Egido J
Kidney Int Suppl; 2002 Dec; (82):S12-22. PubMed ID: 12410849
[TBL] [Abstract][Full Text] [Related]
3. Renal tubular hypertrophy induced by angiotensin II.
Wolf G; Ziyadeh FN
Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
Wolf G
Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
6. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
Matsumoto K; Morishita R; Moriguchi A; Tomita N; Yo Y; Nishii T; Nakamura T; Higaki J; Ogihara T
Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin as a renal growth promoting factor.
Wolf G
Adv Exp Med Biol; 1995; 377():225-36. PubMed ID: 7484425
[TBL] [Abstract][Full Text] [Related]
8. Role of the renin-angiotensin system in vascular diseases: expanding the field.
Ruiz-Ortega M; Lorenzo O; Rupérez M; Esteban V; Suzuki Y; Mezzano S; Plaza JJ; Egido J
Hypertension; 2001 Dec; 38(6):1382-7. PubMed ID: 11751722
[TBL] [Abstract][Full Text] [Related]
9. Kangxianling decoction prevents renal fibrosis in rats with 5/6 nephrectomy and inhibits Ang II-induced ECM production in glomerular mesangial cells.
Ji J; Tao P; He L
J Pharmacol Sci; 2019 Apr; 139(4):367-372. PubMed ID: 30929858
[TBL] [Abstract][Full Text] [Related]
10. Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis.
Ruíz-Ortega M; Gómez-Garre D; Alcázar R; Palacios I; Bustos C; González S; Plaza JJ; González E; Egido J
J Hypertens Suppl; 1994 Jul; 12(4):S51-8. PubMed ID: 7965275
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory properties of drugs acting on the renin-angiotensin system.
Sironi L; Nobili E; Gianella A; Gelosa P; Tremoli E
Drugs Today (Barc); 2005 Sep; 41(9):609-22. PubMed ID: 16341292
[TBL] [Abstract][Full Text] [Related]
12. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system.
Hollenberg NK; Fisher ND; Price DA
Hypertension; 1998 Sep; 32(3):387-92. PubMed ID: 9740600
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts.
Ruiz-Ortega M; Lorenzo O; Egido J
Kidney Int Suppl; 1998 Dec; 68():S41-5. PubMed ID: 9839282
[TBL] [Abstract][Full Text] [Related]
14. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway.
Wolf G
Kidney Int; 2006 Dec; 70(11):1914-9. PubMed ID: 16985515
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
Kim S; Iwao H
Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
[TBL] [Abstract][Full Text] [Related]
16. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
Taniyama Y; Morishita R; Nakagami H; Moriguchi A; Sakonjo H; Shokei-Kim ; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Circulation; 2000 Jul; 102(2):246-52. PubMed ID: 10889138
[TBL] [Abstract][Full Text] [Related]
17. Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II-Induced Kidney Fibrosis.
Qian Y; Peng K; Qiu C; Skibba M; Huang Y; Xu Z; Zhang Y; Hu J; Liang D; Zou C; Wang Y; Liang G
J Pharmacol Exp Ther; 2016 Jan; 356(1):32-42. PubMed ID: 26514795
[TBL] [Abstract][Full Text] [Related]
18. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
19. Human renal fibroblasts derived from normal and fibrotic kidneys show differences in increase of extracellular matrix synthesis and cell proliferation upon angiotensin II exposure.
Schüttert JB; Liu MH; Gliem N; Fiedler GM; Zopf S; Mayer C; Müller GA; Grunewald RW
Pflugers Arch; 2003 Jun; 446(3):387-93. PubMed ID: 12684791
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.
Esteban V; Lorenzo O; Rupérez M; Suzuki Y; Mezzano S; Blanco J; Kretzler M; Sugaya T; Egido J; Ruiz-Ortega M
J Am Soc Nephrol; 2004 Jun; 15(6):1514-29. PubMed ID: 15153562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
